These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32526460)

  • 1. A large number of COVID-19 interventional clinical trials were registered soon after the pandemic onset: a descriptive analysis.
    Nasrallah AA; Farran SH; Nasrallah ZA; Chahrour MA; Salhab HA; Fares MY; Khachfe HH; Akl EA
    J Clin Epidemiol; 2020 Sep; 125():170-178. PubMed ID: 32526460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms.
    de Lusignan S; Jones N; Dorward J; Byford R; Liyanage H; Briggs J; Ferreira F; Akinyemi O; Amirthalingam G; Bates C; Lopez Bernal J; Dabrera G; Eavis A; Elliot AJ; Feher M; Krajenbrink E; Hoang U; Howsam G; Leach J; Okusi C; Nicholson B; Nieri P; Sherlock J; Smith G; Thomas M; Thomas N; Tripathy M; Victor W; Williams J; Wood I; Zambon M; Parry J; O'Hanlon S; Joy M; Butler C; Marshall M; Hobbs FDR
    JMIR Public Health Surveill; 2020 Jul; 6(3):e19773. PubMed ID: 32484782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.
    Gianola S; Jesus TS; Bargeri S; Castellini G
    PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry.
    Xu P; Xing X; Yu K; Lv Z; Cui H; Shi Y; Chang T; Zhang D; Zhang Y; Wang K; Lu J; Huang Q; Li X; Cui Y; Shi L; Wang T; Niu J; Wang J
    Emerg Microbes Infect; 2020 Dec; 9(1):1695-1701. PubMed ID: 32615862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
    Mehta HB; Ehrhardt S; Moore TJ; Segal JB; Alexander GC
    BMJ Open; 2020 Jun; 10(6):e039978. PubMed ID: 32518212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evidence mapping and analysis of registered COVID-19 clinical trials in China.
    Lu L; Li F; Wen H; Ge S; Zeng J; Luo W; Wang L; Tang C; Xu N
    BMC Med; 2020 Jun; 18(1):167. PubMed ID: 32493331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of trials currently testing treatment and prevention of COVID-19.
    Fragkou PC; Belhadi D; Peiffer-Smadja N; Moschopoulos CD; Lescure FX; Janocha H; Karofylakis E; Yazdanpanah Y; Mentré F; Skevaki C; Laouénan C; Tsiodras S;
    Clin Microbiol Infect; 2020 Aug; 26(8):988-998. PubMed ID: 32454187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19).
    Zhu RF; Gao YL; Robert SH; Gao JP; Yang SG; Zhu CT
    J Transl Med; 2020 Jul; 18(1):274. PubMed ID: 32631442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis.
    Cunniffe NG; Gunter SJ; Brown M; Burge SW; Coyle C; De Soyza A; Dymond T; Esmail H; Francis DP; Galloway J; Galloway JB; Gkrania-Klotsas E; Greenaway J; Katritsis G; Kanagaratnam P; Knolle MD; Leonard K; McIntyre ZC; Prudon B; Rampling T; Torok ME; Warne B; Yates M; Matheson NJ; Su L; Villar S; Stewart GD; Toshner M
    BMJ Open; 2020 Oct; 10(10):e044566. PubMed ID: 33020111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era.
    Lee J; Shin HW; Lee JY; Kim JS; Yang JW; Lee KH; Kronbichler A; Shin JI
    Medicina (Kaunas); 2020 Jun; 56(6):. PubMed ID: 32604775
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
    Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
    Duvignaud A; Lhomme E; Pistone T; Onaisi R; Sitta R; Journot V; Nguyen D; Peiffer-Smadja N; Crémer A; Bouchet S; Darnaud T; Poitrenaud D; Piroth L; Binquet C; Michel JF; Lefèvre B; Lebeaux D; Lebel J; Dupouy J; Roussillon C; Gimbert A; Wittkop L; Thiébaut R; Orne-Gliemann J; Joseph JP; Richert L; Anglaret X; Malvy D;
    Trials; 2020 Oct; 21(1):846. PubMed ID: 33050924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
    Pimentel J; Andersson N
    Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities.
    Mainoli B; Machado T; Duarte GS; Prada L; Gonçalves N; Ferreira JJ; Costa J
    BMC Med Res Methodol; 2021 Feb; 21(1):42. PubMed ID: 33637044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.